SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vasomedical Inc. -- Ignore unavailable to you. Want to Upgrade?


To: Marc Phelan who wrote (1413)2/5/2001 8:42:40 AM
From: JHP  Respond to of 1605
 
i believe athletes in taiwan have been using EECP for
at least 3 years. Ask heartsdoc on 11 wall,he can fill you in.
regards john



To: Marc Phelan who wrote (1413)2/6/2001 7:56:35 AM
From: John Soileau  Read Replies (1) | Respond to of 1605
 
Good to see the "secrecy" going away. That's been frustrating about VASO for
a while, the word not really getting out. My sister is a cardio nurse, and heard about
it only in the last 4-5 months, from a "maverick" cardiologist in the major city
she works in. The other MDs she works with are either still not on board, or just now getting
interested (old dog new tricks-- MDs are no better at changing mindset than the rest of us).
I was REALLY
happy to hear of the Journal cover article, I think that will work wonders in getting
utilization up.
"Joe Sixpack" is blue sky in this stock, not sure if/how/when vasoconstriction would
ever be available to the general public but if it ever were this stock would roar. I really
believe it's a noninvasive route to a healthier population. US cardio morbidity and
mortality statistics are absolutely horrible.